News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shah Preetam
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2023 |
4
| Shah Preetam (CFO & CBO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 6,648 shares
@ $1.53, valued at
$10.2k
|
|
| 09/19/2022 |
4
| Shah Preetam (CFO & CBO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 15,642 shares
@ $0.7694, valued at
$12k
Exercised 50,000 restricted stock units
@ $0 |
|
| 04/04/2022 |
4
| Shah Preetam (CFO & CBO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 51,250 shares
@ $0
Granted 66,001 shares
@ $0
Paid exercise price by delivering 24,820 shares
@ $0.83, valued at
$20.6k
Granted 102,500 options to buy
@ $0.83, valued at
$85.1k
|
|
| 11/15/2021 |
4
| Shah Preetam (CFO & CBO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $1.54, valued at
$30.8k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|